Current status of immunotherapy for non-small cell lung cancer

• Main Authors: Tao Yang (Author), Yilin Xiong (Author), Yufei Zeng (Author), Yan Wang (Author), Jing Zeng (Author), Jie Liu (Author), Shangfu Xu (Author), Li-Sheng Li (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Nowadays, lung cancer is still the deadliest oncological disease in the world. Among them, non-small cell lung cancer (NSCLC) accounts for 80%∼85% of all lung cancers, and its 5-year survival rate is less than 15%, making the situation critical. In the past decades, despite some clinical advances in...